Agent for reducing risk in onset of disease ascribable to non-dipper circadian rhythm of blood pressure
AssigneeCalpis Co., Ltd.
InventorsMari TAKAHASHI, Naoyuki YAMAMOTO, Kazuhisa YAMADA, Toshirou IKETANI
Life of this patent
Estimating the term…
Loading patent…
AssigneeCalpis Co., Ltd.
InventorsMari TAKAHASHI, Naoyuki YAMAMOTO, Kazuhisa YAMADA, Toshirou IKETANI
Estimating the term…
An agent for reducing risk in onset of diseases ascribable to non-dipping circadian profile of blood pressure is provided. This agent is capable of effectively lowering SBP from night to early morning in individuals with non-dipping circadian profile of blood pressure, in particular, normal individuals with normal SBP and DBP among them, and is thus capable of reducing risk in onset, particularly likely in the morning, of diseases caused by circadian variation of blood pressure. The agent is intended for administration to such subjects, and contains a hydrolysate or a concentrate thereof, containing Val-Pro-Pro and Ile-Pro-Pro and obtained by hydrolysis of animal milk protein.
A method for increasing magnitude of nocturnal or early morning decline in mean systolic blood pressure of a non-dipper individual, comprising orally administering a animal milk protein hydrolysate containing Ile-Pro-Pro tripeptide and Val-Pro-Pro tripeptide, or a concentrate thereof, to the non-dipper individual,
Dependencies are inferred from the claim text.